Stay updated on Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6 on the study record page, signaling a refresh to the latest version.
    Difference
    0.1%
    Check dated 2026-08-29T19:54:01.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision label updated to v3.6.5 (replacing v3.6.4), indicating a minor CMS update. The change does not modify study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-08-08T17:51:42.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.6.3 to v3.6.4, signaling a newer build of the page. No study content or data were changed.
    Difference
    0.1%
    Check dated 2026-07-25T10:38:21.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.6.2 to v3.6.3, indicating a minor update to the page template or metadata. It does not alter study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-03T21:59:40.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The revision tag on the study page was updated from v3.6.0 to v3.6.2. This reflects a recent page update without substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-26T19:49:47.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate the study is no longer looking for participants, signaling that enrollment has closed. Added navigation and help items—'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study'—along with a page revision note 'Revision: v3.6.0' to reflect updates to the study record layout.
    Difference
    0.4%
    Check dated 2026-06-12T11:40:56.000Z thumbnail image

Stay in the know with updates to Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.